Bridgewater Associates LP Sells 17,069 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Bridgewater Associates LP lessened its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 27.6% during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 44,671 shares of the medical equipment provider's stock after selling 17,069 shares during the period. Bridgewater Associates LP's holdings in Intuitive Surgical were worth $23,316,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently modified their holdings of the business. Atala Financial Inc purchased a new stake in Intuitive Surgical during the fourth quarter worth about $25,000. Hurley Capital LLC purchased a new stake in shares of Intuitive Surgical during the 4th quarter worth approximately $28,000. Berbice Capital Management LLC bought a new stake in shares of Intuitive Surgical in the 4th quarter worth approximately $26,000. BankPlus Trust Department bought a new position in Intuitive Surgical during the fourth quarter valued at $28,000. Finally, Summit Securities Group LLC bought a new position in Intuitive Surgical during the fourth quarter valued at $30,000. 83.64% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In related news, Director Amal M. Johnson sold 4,635 shares of the company's stock in a transaction that occurred on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total value of $2,626,191.00. Following the sale, the director now owns 12,275 shares in the company, valued at $6,955,015. This represents a 27.41 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CFO Jamie Samath sold 269 shares of the business's stock in a transaction on Monday, February 10th. The stock was sold at an average price of $590.00, for a total value of $158,710.00. Following the completion of the sale, the chief financial officer now directly owns 3,282 shares in the company, valued at $1,936,380. This trade represents a 7.58 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 33,754 shares of company stock valued at $17,691,621. Company insiders own 0.70% of the company's stock.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on ISRG. Wells Fargo & Company increased their price target on Intuitive Surgical from $630.00 to $687.00 and gave the stock an "overweight" rating in a research note on Friday, January 24th. UBS Group boosted their target price on shares of Intuitive Surgical from $500.00 to $560.00 and gave the company a "neutral" rating in a report on Monday, January 27th. Royal Bank of Canada raised their price target on Intuitive Surgical from $611.00 to $641.00 in a report on Monday, January 27th. CICC Research assumed coverage on Intuitive Surgical in a research note on Monday, January 27th. They set a "neutral" rating and a $550.00 price objective on the stock. Finally, Raymond James raised their target price on Intuitive Surgical from $560.00 to $688.00 and gave the stock an "outperform" rating in a research note on Friday, January 24th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have assigned a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus price target of $611.81.

Intuitive Surgical Stock Up 0.3 %

Shares of Intuitive Surgical stock traded up $1.40 during trading on Friday, reaching $482.74. 1,618,989 shares of the stock were exchanged, compared to its average volume of 1,599,026. The stock's fifty day moving average is $522.23 and its 200 day moving average is $532.02. The firm has a market cap of $171.94 billion, a price-to-earnings ratio of 75.31, a price-to-earnings-growth ratio of 5.85 and a beta of 1.55. Intuitive Surgical, Inc. has a 1 year low of $364.17 and a 1 year high of $616.00.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.